Felix Deanda

665 total citations
13 papers, 487 citations indexed

About

Felix Deanda is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Felix Deanda has authored 13 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Virology and 6 papers in Infectious Diseases. Recurrent topics in Felix Deanda's work include HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical and Molecular Research (4 papers). Felix Deanda is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS drug development and treatment (6 papers) and Biochemical and Molecular Research (4 papers). Felix Deanda collaborates with scholars based in United States, Japan and Switzerland. Felix Deanda's co-authors include Mark Underwood, Kendra E. Hightower, Brian A. Johns, Wieslaw M. Kazmierski, Kurt Weaver, Takahiro Seki, Masanori Kobayashi, Hanbiao Yang, H. Luke Carter and Ruolan Wang and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Felix Deanda

13 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felix Deanda United States	11	321	289	221	78	50	13	487
Satoki Doi Japan	6	273 0.9×	234 0.8×	186 0.8×	100 1.3×	57 1.1×	9	460
Yasushi Tojo Japan	8	197 0.6×	210 0.7×	139 0.6×	70 0.9×	48 1.0×	9	372
Brett S. Robinson United States	6	445 1.4×	424 1.5×	169 0.8×	62 0.8×	57 1.1×	9	633
S.L. Irving United Kingdom	7	186 0.6×	218 0.8×	326 1.5×	152 1.9×	43 0.9×	8	547
Stephen A. Fakhoury United States	8	296 0.9×	252 0.9×	251 1.1×	215 2.8×	36 0.7×	10	541
Federica Orvieto Italy	11	129 0.4×	92 0.3×	227 1.0×	155 2.0×	34 0.7×	17	440
S. Benzaria France	11	370 1.2×	111 0.4×	335 1.5×	139 1.8×	183 3.7×	25	638
Joan Zugay-Murphy United States	8	130 0.4×	103 0.4×	202 0.9×	68 0.9×	44 0.9×	9	363
S. Foundling United States	10	165 0.5×	154 0.5×	284 1.3×	57 0.7×	22 0.4×	12	457
Alessia Petrocchi Italy	11	258 0.8×	146 0.5×	298 1.3×	138 1.8×	92 1.8×	18	561

Countries citing papers authored by Felix Deanda

Since Specialization

Citations

This map shows the geographic impact of Felix Deanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felix Deanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felix Deanda more than expected).

Fields of papers citing papers by Felix Deanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felix Deanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felix Deanda. The network helps show where Felix Deanda may publish in the future.

Co-authorship network of co-authors of Felix Deanda

This figure shows the co-authorship network connecting the top 25 collaborators of Felix Deanda. A scholar is included among the top collaborators of Felix Deanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felix Deanda. Felix Deanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Beilhartz, Greg L., et al.. (2014). Inhibition of the Ribonuclease H Activity of HIV-1 Reverse Transcriptase by GSK5750 Correlates with Slow Enzyme-Inhibitor Dissociation. Journal of Biological Chemistry. 289(23). 16270–16277. 25 indexed citations

Deanda, Felix, Kendra E. Hightower, Robert T. Nolte, et al.. (2013). Dolutegravir Interactions with HIV-1 Integrase-DNA: Structural Rationale for Drug Resistance and Dissociation Kinetics. PLoS ONE. 8(10). e77448–e77448. 44 indexed citations

Vavro, Cindy, Samiul Hasan, Joseph Horton, et al.. (2013). Prevalent Polymorphisms in Wild-Type HIV-1 Integrase Are Unlikely To Engender Drug Resistance to Dolutegravir (S/GSK1349572). Antimicrobial Agents and Chemotherapy. 57(3). 1379–1384. 17 indexed citations

Duan, Maosheng, Wieslaw M. Kazmierski, Pek Y. Chong, et al.. (2011). Discovery of novel pyridyl carboxamides as potent CCR5 antagonists and optimization of their pharmacokinetic profile in rats. Bioorganic & Medicinal Chemistry Letters. 21(21). 6470–6475. 9 indexed citations

Hightower, Kendra E., Ruolan Wang, Felix Deanda, et al.. (2011). Dolutegravir (S/GSK1349572) Exhibits Significantly Slower Dissociation than Raltegravir and Elvitegravir from Wild-Type and Integrase Inhibitor-Resistant HIV-1 Integrase-DNA Complexes. Antimicrobial Agents and Chemotherapy. 55(10). 4552–4559. 182 indexed citations

Patnaik, Samarjit, Kirk L. Stevens, Felix Deanda, et al.. (2009). Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 19(11). 3136–3140. 20 indexed citations

Chamberlain, Stanley D., Anikó M. Redman, Samarjit Patnaik, et al.. (2008). Optimization of a series of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine inhibitors of IGF-1R: Elimination of an acid-mediated decomposition pathway. Bioorganic & Medicinal Chemistry Letters. 19(2). 373–377. 15 indexed citations

Chamberlain, Stanley D., Joseph W. Wilson, Felix Deanda, et al.. (2008). Discovery of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidines: Potent inhibitors of the IGF-1R receptor tyrosine kinase. Bioorganic & Medicinal Chemistry Letters. 19(2). 469–473. 27 indexed citations

Kazmierski, Wieslaw M., Christopher Aquino, Brian A. Chauder, et al.. (2008). Discovery of Bioavailable 4,4-Disubstituted Piperidines as Potent Ligands of the Chemokine Receptor 5 and Inhibitors of the Human Immunodeficiency Virus-1. Journal of Medicinal Chemistry. 51(20). 6538–6546. 26 indexed citations

10.

Deanda, Felix, Eugene L. Stewart, Michael J. Reno, & David H. Drewry. (2008). Kinase-Targeted Library Design through the Application of the PharmPrint Methodology. Journal of Chemical Information and Modeling. 48(12). 2395–2403. 15 indexed citations

11.

McDonald, Octerloney B., Karen Lackey, Ronda G. Davis‐Ward, et al.. (2006). Aza-stilbenes as potent and selective c-RAF inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5378–5383. 14 indexed citations

12.

Deanda, Felix & Eugene L. Stewart. (2004). Application of the PharmPrint Methodology to Two Protein Kinases. Journal of Chemical Information and Computer Sciences. 44(5). 1803–1809. 8 indexed citations

13.

Kazmierski, Wieslaw M., Neil Bifulco, Hanbiao Yang, et al.. (2003). Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors. Bioorganic & Medicinal Chemistry. 11(13). 2663–2676. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact